These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3598157

  • 21. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
    Alexander GJ, Fagan EA, Guarner P, Rolando N, Brahm J, Eddleston AL, Williams R.
    J Hepatol; 1986; 3 Suppl 2():S183-8. PubMed ID: 3298406
    [Abstract] [Full Text] [Related]

  • 22. A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.
    Carreño V, Porres JC, Mora I, Gutiez J, Quiroga JA, Ramón y Cajal S, Oliva H, Compernolle C, Bartolomé J.
    Antiviral Res; 1987 Oct; 8(3):125-37. PubMed ID: 3501274
    [Abstract] [Full Text] [Related]

  • 23. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
    Brook MG, Karayiannis P, Thomas HC.
    Hepatology; 1989 Nov; 10(5):761-3. PubMed ID: 2680866
    [Abstract] [Full Text] [Related]

  • 24. Treatment of chronic hepatitis B with recombinant leukocyte interferon and cyanidanol.
    Kanai K, Morioka S, Nakajima T, Ishii H, Tamakoshi K, Matsuda H, Matsumoto M, Mizushima N, Takehira Y.
    Gastroenterol Jpn; 1988 Feb; 23(1):44-8. PubMed ID: 3350278
    [Abstract] [Full Text] [Related]

  • 25. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
    Lai CL, Lok AS, Lin HJ, Wu PC, Yeoh EK, Yeung CY.
    Lancet; 1987 Oct 17; 2(8564):877-80. PubMed ID: 2889081
    [Abstract] [Full Text] [Related]

  • 26. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
    Eisenburg J, Caselmann W, Eder M, Pape GR.
    Fortschr Med; 1988 Jul 20; 106(21):431-7. PubMed ID: 3146536
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon.
    Lin CY.
    Kidney Int; 1995 Jan 20; 47(1):225-30. PubMed ID: 7731150
    [Abstract] [Full Text] [Related]

  • 28. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
    Stancek D, Hajnická V, Blaskovicová H, Sudová J, Laktis K, Janota S, Jezek P.
    Acta Virol; 1990 Sep 20; 34(5):457-66. PubMed ID: 1981456
    [Abstract] [Full Text] [Related]

  • 29. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
    McDonald JA, Caruso L, Karayiannis P, Scully LJ, Harris JR, Forster GE, Thomas HC.
    Hepatology; 1987 Sep 20; 7(4):719-23. PubMed ID: 3038722
    [Abstract] [Full Text] [Related]

  • 30. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G, Santantonio T, Monno L, Milella M, Luchena N, Angarano G.
    Hepatogastroenterology; 1988 Apr 20; 35(2):57-61. PubMed ID: 3371847
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Recombinant alpha 2-interferon treatment in children with chronic hepatitis B.
    La Banda F, Ruiz Moreno M, Carreño V, Bartolome J, Gutiez J, Ramon y Cajal S, Moreno A, Mora I, Carlos Porres J.
    Lancet; 1988 Jan 30; 1(8579):250. PubMed ID: 2893078
    [No Abstract] [Full Text] [Related]

  • 35. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
    Ruiz Moreno M, Jimenez J, Porres JC, Bartolomé J, Moreno A, Carreño V.
    Digestion; 1990 Jan 30; 45(1):26-33. PubMed ID: 2187723
    [Abstract] [Full Text] [Related]

  • 36. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection.
    Kay MH, Wyllie R, Deimler C, Caulfield M, Steffen R, Baetz-Greenwalt B.
    J Pediatr; 1993 Dec 30; 123(6):1001-4. PubMed ID: 8229507
    [Abstract] [Full Text] [Related]

  • 37. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W, Paszkiewicz J, Korczak A, Własiuk M, Zółtowska A, Szutowicz A, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1993 Dec 30; 41(3-4):241-51. PubMed ID: 8129568
    [Abstract] [Full Text] [Related]

  • 38. The value of quantitative measurement of HBeAg and HBsAg before interferon-alpha treatment of chronic hepatitis B in children.
    Burczynska B, Madalinski K, Pawlowska J, Woynarowski M, Socha J, Gerlich WH, Willems WR, Wozniewicz B, Stachowski J.
    J Hepatol; 1994 Dec 30; 21(6):1097-102. PubMed ID: 7699234
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.